Summary
Abdominal malignant tumours represent one of the groups of oncological pathologies with the highest prevalence and mortality. Annually, new cancer cases related to organs in the abdomen (pancreas, liver, kidney, etc.) are diagnosed globally, representing more than 1.4 million annual deaths worldwide. Particularly, pancreatic cancer is the fourth cause of death by cancer in Europe, but it has the lowest 5-year survival rate among the common cancers.
Sycai Technologies S.L. (SYCAI) is a deep-tech company that has developed an Artificial Intelligence digital tool to assist radiologists to detect and classify abdominal lesions through imaging. Currently, our tool prevents the abdominal lesions from progressing to pancreatic cancer with an accuracy superior to the standard identification procedures.
By integrating this assistant in the workflow of radiologists with our “0-clicks” approach, the information will be easily accessible by professionals to accelerate the identification of precursor lesions, avoiding invasive tests, surgeries, and patient complications.
At SYCAI we have the vision to provide non-invasive tools to assist in the early-stage diagnosis of any type of abdominal cancer. We aim to impact our society positively, contributing to improving the quality of life of patients with abdominal lesions with a low probability of evolving towards malignant lesions. Additionally, our solutions will improve the dedication of resources to patients needing prioritisation in cancer care according to the status of lesions. Therefore, SYCAI contributes to public expenditure savings for a sustainable and resilient European healthcare system.
Sara Toledano, CEO and Julia Rodríguez, CSO, apply to the Women TechEU programme since they are eager to improve their leadership skills to face the challenge of market entrance in Europe and to be prepared for sales, operations and team growth.
Sycai Technologies S.L. (SYCAI) is a deep-tech company that has developed an Artificial Intelligence digital tool to assist radiologists to detect and classify abdominal lesions through imaging. Currently, our tool prevents the abdominal lesions from progressing to pancreatic cancer with an accuracy superior to the standard identification procedures.
By integrating this assistant in the workflow of radiologists with our “0-clicks” approach, the information will be easily accessible by professionals to accelerate the identification of precursor lesions, avoiding invasive tests, surgeries, and patient complications.
At SYCAI we have the vision to provide non-invasive tools to assist in the early-stage diagnosis of any type of abdominal cancer. We aim to impact our society positively, contributing to improving the quality of life of patients with abdominal lesions with a low probability of evolving towards malignant lesions. Additionally, our solutions will improve the dedication of resources to patients needing prioritisation in cancer care according to the status of lesions. Therefore, SYCAI contributes to public expenditure savings for a sustainable and resilient European healthcare system.
Sara Toledano, CEO and Julia Rodríguez, CSO, apply to the Women TechEU programme since they are eager to improve their leadership skills to face the challenge of market entrance in Europe and to be prepared for sales, operations and team growth.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101113932 |
| Start date: | 01-06-2023 |
| End date: | 30-11-2023 |
| Total budget - Public funding: | - 75 000,00 Euro |
Cordis data
Original description
Abdominal malignant tumours represent one of the groups of oncological pathologies with the highest prevalence and mortality. Annually, new cancer cases related to organs in the abdomen (pancreas, liver, kidney, etc.) are diagnosed globally, representing more than 1.4 million annual deaths worldwide. Particularly, pancreatic cancer is the fourth cause of death by cancer in Europe, but it has the lowest 5-year survival rate among the common cancers.Sycai Technologies S.L. (SYCAI) is a deep-tech company that has developed an Artificial Intelligence digital tool to assist radiologists to detect and classify abdominal lesions through imaging. Currently, our tool prevents the abdominal lesions from progressing to pancreatic cancer with an accuracy superior to the standard identification procedures.
By integrating this assistant in the workflow of radiologists with our “0-clicks” approach, the information will be easily accessible by professionals to accelerate the identification of precursor lesions, avoiding invasive tests, surgeries, and patient complications.
At SYCAI we have the vision to provide non-invasive tools to assist in the early-stage diagnosis of any type of abdominal cancer. We aim to impact our society positively, contributing to improving the quality of life of patients with abdominal lesions with a low probability of evolving towards malignant lesions. Additionally, our solutions will improve the dedication of resources to patients needing prioritisation in cancer care according to the status of lesions. Therefore, SYCAI contributes to public expenditure savings for a sustainable and resilient European healthcare system.
Sara Toledano, CEO and Julia Rodríguez, CSO, apply to the Women TechEU programme since they are eager to improve their leadership skills to face the challenge of market entrance in Europe and to be prepared for sales, operations and team growth.
Status
SIGNEDCall topic
HORIZON-EIE-2022-SCALEUP-02-02Update Date
31-07-2023
Images
No images available.
Geographical location(s)
